Transporters affecting biochemical test results: Creatinine-drug interactions

被引:27
作者
Chu, X. [1 ]
Bleasby, K. [1 ]
Chan, G. H. [1 ]
Nunes, I. [2 ]
Evers, R. [1 ]
机构
[1] Merck Sharp & Dohme Corp, Dept Pharmacokinet Pharmacodynam & Drug Metab, Kenilworth, NJ 07033 USA
[2] Merck Sharp & Dohme Corp, GRA Onc Immunol Biol & Devices, Kenilworth, NJ USA
关键词
D O I
10.1002/cpt.445
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Creatinine is eliminated by the kidneys through a combination of glomerular filtration and active transport. Drug-induced increases in serum creatinine (SCr) and/or reduced creatinine renal clearance are used as a marker for acute kidney injury. However, inhibition of active transport of creatinine can result in reversible and, therefore, benign increases in SCr levels. Herein, the transporters involved in creatinine clearance are discussed, in addition to limitations of using creatinine as a biomarker for kidney damage.
引用
收藏
页码:437 / 440
页数:4
相关论文
共 5 条
  • [1] [Anonymous], 2012, GUID IND
  • [2] Chu Xiaoyan, 2016, Drug Metab Dispos, V44, P1498, DOI 10.1124/dmd.115.067694
  • [3] Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium
    Hillgren, K. M.
    Keppler, D.
    Zur, A. A.
    Giacomini, K. M.
    Stieger, B.
    Cass, C. E.
    Zhang, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (01) : 52 - 63
  • [4] Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in Adults A Systematic Review
    Levey, Andrew S.
    Becker, Cassandra
    Inker, Lesley A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (08): : 837 - 846
  • [5] Renal Transport of Organic Anions and Cations
    Pelis, Ryan M.
    Wright, Stephen H.
    [J]. COMPREHENSIVE PHYSIOLOGY, 2011, 1 (04) : 1795 - 1835